AttendMe Owl Logo
AttendMe
Evidence Evolution
Hepatobiliary SurgeryHepatobiliary Surgery

How This Evidence Evolved

Pancreaticoduodenectomy Volume-Outcome

The Relationship Between Hospital Volume and Surgical Mortality in Complex Cancer Operations

24.3

Timeline

Signal

Early observations and pilot data that first suggested a new direction

A 1998 retrospective SEER–Medicare cohort examined major cancer operations in patients aged 65 or older. For pancreatectomy, 30-day mortality was 12.9% in low-volume hospitals versus 5.8% in high-volume hospitals. Adjustment for case mix and other patient factors did not remove the association. This was evidence about pancreatectomy overall, rather than pancreaticoduodenectomy alone.
Proof

Landmark RCTs and pivotal trials that established the evidence base

Birkmeyer and colleagues examined 2.5 million procedures across 14 operation types between 1994 and 1999. Adjusted mortality for pancreatic resection was 16.3% at very-low-volume hospitals and 3.8% at very-high-volume hospitals. The strength of the volume association varied by operation. These observational data supported hospital selection and regionalization, while requiring attention to patient selection and other measures of surgical quality.
Extension

Follow-up studies, subgroup analyses, and real-world validation

Birkmeyer's surgeon-volume analysis found lower operative mortality with higher surgeon volume. For pancreatic resection, the adjusted odds ratio for low- versus high-volume surgeons was 3.61; surgeon volume accounted for 55% of the apparent hospital-volume effect. A prospective regional Dutch cohort after centralization from July 2005 reported in-hospital mortality of 2.6%, compared with 24.4% in the previous regional cohort. These findings concern a specific region, rather than all Dutch hospitals.
Guidelines

Integration into clinical practice guidelines and recommendations

A study applying Leapfrog standards used annual pancreatectomy volumes of ≥20 per hospital and ≥10 per surgeon. Outcomes still varied among qualifying providers; volume alone did not establish quality.
Now

Current standard of care and ongoing research directions

Pancreatic-surgery volume is associated with outcomes, but definitions and settings matter. A regional Dutch cohort of 76 resections reported in-hospital mortality of 2.6% after centralization versus 24.4% historically; annual resections increased from 10 to 33. This is not a universal mortality benchmark or proof of causation. A study of Leapfrog-qualified providers found substantial variation despite meeting volume standards. Questions include failure-to-rescue and textbook outcomes, patient selection, preoperative optimization and whether telemedicine or hub-and-spoke care improves access.

Landmark Trials in This Story

Begg et al.1998Landmark

Impact of hospital volume on operative mortality for major cancer surgery

Thirty-day mortality after pancreatectomy: low-volume 12.9% vs high-volume 5.8% (P=.004 for volume association).

JAMARetrospective CohortN=5,013
Birkmeyer Volume-Outcome2002Landmark

Hospital volume and surgical mortality in the United States

Adjusted operative mortality after pancreatic resection: very-low-volume 16.3% vs very-high-volume 3.8%

New England journal of medicineRetrospective Cohort
Birkmeyer Surgeon Volume2003Landmark

Surgeon volume and operative mortality in the United States

Operative mortality by surgeon volume — pancreatic resection mortality inversely correlated with individual surgeon volume

New England journal of medicineRetrospective CohortN=474,108
Leapfrog volume standards analysis2021

Variation in outcomes across surgeons meeting the Leapfrog volume standard for complex oncologic surgery.

Pancreatectomy complications and 90-day mortality: high-volume surgeon/hospital OR 0.73 (95% CI 0.66–0.80) and OR 0.66 (95% CI 0.56–0.76), respectively.

CancerRetrospective cohortN=112,154
Dutch regional centralization cohort2010

Reduction of in-hospital mortality following regionalisation of pancreatic surgery in the south-east of the Netherlands.

In-hospital mortality: post-regionalization 2.6% vs historical cohort 24.4% (P<0.01).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyComparative cohortN=76

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Frequently Asked Questions

How much does hospital volume affect mortality for pancreaticoduodenectomy?+
The 2002 Birkmeyer study examined 2.5 million procedures across 14 types. Adjusted operative mortality for pancreatic resection was 16.3% at very-low-volume hospitals and 3.8% at very-high-volume hospitals. The study supports an association between volume and mortality; its abstract does not define the annual-volume cutoffs.
What is the recommended minimum volume for a center performing pancreaticoduodenectomy?+
For pancreatectomy, a study applying Leapfrog standards used annual minimum volumes of 20 for hospitals and 10 for surgeons. Outcomes still varied among providers meeting those standards, so volume alone is insufficient as a quality indicator. A regional Dutch cohort reported in-hospital mortality of 2.6% after centralization versus 24.4% previously.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026